Erythromycin strengthens the defective lower esophageal sphincter in patients with gastroesophageal reflux disease

scientific article published on 01 January 1994

Erythromycin strengthens the defective lower esophageal sphincter in patients with gastroesophageal reflux disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0002-9610(94)90069-8
P698PubMed publication ID8311129

P50authorAlexander G. Little, IIIQ97102858
Gail L. SierenQ105441277
Joseph B. FayadQ105441319
P2093author name stringA Tran
A Pennathur
M Cioppi
P433issue1
P407language of work or nameEnglishQ1860
P921main subjecterythromycinQ213511
gastroesophageal reflux diseaseQ223591
P304page(s)169-72; discussion 172-3
P577publication date1994-01-01
P1433published inThe American Journal of SurgeryQ15762745
P1476titleErythromycin strengthens the defective lower esophageal sphincter in patients with gastroesophageal reflux disease
P478volume167

Reverse relations

cites work (P2860)
Q50193107Duodenogastric and gastroesophageal bile reflux
Q33703880Effect of atilmotin, a motilin receptor agonist, on esophageal, lower esophageal sphincter, and gastric pressures
Q35296967Erythromycin as a prokinetic agent in preterm neonates: a systematic review
Q40836602Functional gut disorders: from motility to sensitivity disorders. A review of current and investigational drugs for their management
Q91188011Motilin: from gastric motility stimulation to hunger signalling
Q33691798Prokinetic agents in the surgical patient
Q35290712Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants

Search more.